Published on:

A large study published August 6th in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) has connected higher heart attack survival rates to women patients treated by a female doctor. Heart attacks are the leading cause of death for both men and women in this country. According to the American Heart Association (AHA), a woman dies every 80 seconds from a heart attack. Women are also more likely to die from a heart attack than men, the reasons for which have never been proven.

Women MDs Linked to Heart Attack Survival

The study, entitled “Patient-physician gender concordance and increased mortality among female heart attack patients,” relied on hospital records of 582,000 heart attack patients in Florida hospitals over the nearly 20 year period between 1991 and 2010.

Published on:

“Today, this is the most dangerous place in the developed world to give birth.”                                                                          -USA Today: “Hospitals know how to protect mothers. They just aren’t doing it.” (July 27, 2018)

Last Friday, USA Today published a report with findings from their investigation into hospital records and personal stories and has concluded that hospitals are failing mothers by missing symptoms that indicate serious maternal complications. The report, entitled “Hospitals know how to protect mothers. They just aren’t doing it.,” shared the CDC’s statistic that 50,000 women a year in this country suffer a serious complication during delivery. Around 700 mothers die a year.

These statistics alone might not sound significant given that there are nearly 4 million births a year in the U.S., but the frightening part is that despite being a wealthy, industrialized country, our maternal death rate is getting worse and is the WORST of any developed country. We are the only country besides Sudan and Afghanistan whose maternal death rate is on the rise, despite the belief by many that we have the best care in the world.

Published on:

medical malpractice wrongful death

Levin & Perconti Attorneys Assist Family In $12 Million Award for Failure to Diagnose and Treat Lung Cancer

A jury voted to award $12 million to the family of Doris Newberry after her death following a failure to diagnose and treat her lung cancer. Her family, with the help of Levin & Perconti attorneys John Perconti, Michael Bonamarte and Cari Silverman, were able to prove that the defendants — including family practice doctors Dr. Iza, and Dr. Jeffrey Lindahl of Alexian Brothers Medical Group, as well as radiologist Dr. Jeffrey E. Chung, of Radiological Consultants of Woodstock — failed numerous times to appropriately diagnose and care for Newberry’s cancer. As a result, she experienced pain and suffering and disfigurement, and an untimely death, which could have been prevented had her cancer been diagnosed following a 2010 X-ray which revealed a lung abnormality.

  • Iza saw Newberry several times between June 2008 and August 2010, including an August visit following a July 2010 chest X-ray that showed abnormal findings.
Published on:

A recent study published in the Mayo Clinic Proceedings reveals that 54% of American physicians report feeling burnt out at work. Lead study author, Stanford pediatric physician Daniel S. Tawfik, and his team found that those experiencing burnout were TWO times as likely to have made a major medical error in the last 3 months. Study authors also believe that based on this information, 1/3 of all American physicians are experiencing burnout at any given time.  Researchers describe burnout as “emotional exhaustion or cynicism.”

The study questioned 6,586 physicians in active practice at an American hospital or clinic and asked them to report feelings of burnout, excessive fatigue, recent suicidal thoughts, their thoughts on patient safety on the unit in which they primarily work, as well as those who had made a major medical error. The authors found:

  • 54.3%  of physicians admitted feeling burnt out
Published on:

In April, we covered ProPublica’s investigation into UIC’s renowned child psychiatrist, Dr. Mani Pavuluri.

From 2009-2013, Dr. Pavuluri conducted a study on the effects of lithium in children with bipolar disorder. The study was abruptly cancelled when one of the subjects reported an illness serious enough to notify federal officials. Initially UIC would not disclose the total number of study participants.

Test subjects were given 8 weeks of lithium following a manic episode and then exposed to brain scans to monitor changes. UIC failed to properly oversee the study, only finding out later that their star pediatric psychiatrist had violated FDA standards, general research standards, and university rules to carry out her study.

Published on:

The largest ever medical malpractice verdict was awarded on Monday to now-17-year-old Faith DeGrand from Wyandotte, Michigan. After a two week trial and 2.5 hours of deliberation, the 8 person jury found Detroit Medical Center’s Children’s Hospital of Michigan and two doctors guilty of malpractice, awarding $135 million to the girl.


Doctor Vacationed Twice While Victim Lay Paralyzed

Faith DeGrand was 10 years old when she went to Children’s Hospital of Michigan for a relatively routine pediatric scoliosis surgery. Following protocol for the surgery, a rod and screws were placed in her back to help straighten her spine. Her surgeon inappropriately placed the surgical hardware, causing compression on the young girl’s spine. Immediately following the surgery, Faith experienced severe pain, paralysis of her arms and legs, and lost all bowel and bladder control. She was unable to walk or use the bathroom, bound to a wheelchair and forced to use a catheter. Realizing the placement of the surgical devices was causing Faith’s injuries, another surgeon removed them. However, the damage was already done. Faith spent the next year in a wheelchair and will spend the rest of her life using a catheter and unable to have full control of her arms and legs, a condition known as a quadriparesis.

Published on:

The Center for Justice & Democracy, a consumer rights advocacy group out of New York Law School, has compiled a review of medical malpractice incidents and has publicly shared their findings. Entitled “Medical Malpractice: By the Numbers,” the briefing examines recent medical studies and investigations of both inpatient and outpatient groups and facilities such as hospitals, nursing homes, home health agencies, and hospice organizations.

The data brings deficiencies in medical care into the spotlight, specifically the care Americans receive within hospitals. Below is a summary of information from the report our medical malpractice attorneys think is particularly informative and worth sharing. All data sources can be found in the CJ&D briefing. We have included the page number of the report that contains the source for each statistic.

HOSPITALS:

Published on:

A nearly year long joint NPR/ProPublica investigation into the rising rate of maternal deaths in the U.S. has uncovered the pivotal role that midwives play in the safe delivery of babies. Mothers in the U.S. are dying at a rate three times greater than that of the next closest industrialized country. According to ProPublica, maternal death rates per 100,000 live births are as follows:

  1. United States = 26.4%
  2. France = 7.8%
Published on:

Purdue Pharma, maker of OxyContin and lesser known MS Contin, is facing scrutiny after several recent articles exposed information from a Justice Department investigation into the company. The investigation focused on evidence that showed Purdue’s legal council and executives were aware of the addictive nature of their drugs, including their popularity with drug seekers. Despite knowing their drugs were being misused, the company continued a false marketing campaign that promoted the drug as safer than other opioids because it was less likely to be abused or cause addiction. The company still maintains that they weren’t aware of users abusing their drugs until Maine’s attorney general issued an alert about the drug in 2000, despite federal investigators finding proof that company salespeople were aware as early as 1997, just a year after the release of OxyContin.

The federal investigation ended in 2007 with Purdue Pharma pleading guilty to a felony charge of deceptive advertising and 3 top executives pleading guilty to misdemeanor charges. The company paid $635 million in fines to the government, while the execs did community service and avoided jail time. According to many familiar with the case, Purdue’s executives were given a proverbial hall pass, missing a potentially huge opportunity to throw a roadblock in the now public health crisis that is America’s opioid crisis. Many have called drug company executives behind opioids at the center of the crisis “suited drug pushers,” no better than street drug dealers. Others have said that if they were a minority in street clothes selling these drugs, they’d be locked up. Instead, drug company executives who knowingly market these drugs and force their sales reps to push them on doctors with false claims of safety and less addictive formulations are skating by, continuing to receive large bonuses and stock options while fueling the ongoing drug crisis.

Internal Emails Reveal Awareness of OxyContin’s Street Reputation

Published on:

In fall 2015, stories began circulating that a study had shown that chemo wasn’t already required as part of breast cancer treatment. But after awhile, the conversation started to dwindle. That is until now. Today in Chicago, attendees of the annual meeting of the American Society of Clinical Oncology are hearing study findings that chemotherapy may no longer be required for all women diagnosed with breast cancer. The study, called TAILORx, was a team effort by the U.S. and Canadian governments, as well as several charitable organizations.

Chemo Found to Have No Impact on Early-Stage Breast Cancer Survival Rates

TAILORx began in 2006 and followed 6,800 women from age 18-75 who had received an early stage breast cancer diagnosis, defined as tumors that have not spread to the lymph nodes and range between 1-5 cm. The women must also have tested negative for HER2, a protein found to be a major contributor to breast cancer.